dashboard articles docs

Access to anti-retroviral drugs, male (%): Compare by Country

Browse Access to anti-retroviral drugs, male (%) across 160 countries. Select a country to view an interactive chart with historical data, cross-country comparison, and trend analysis. All data sourced from World Bank.

160 countriesSource: World Bank

Countries with Access to anti-retroviral drugs, male (%) Data— select a country to view interactive chart

Click any country to open an interactive chart with historical Access to anti-retroviral drugs, male (%) trends. You can compare multiple countries, switch time ranges, and download chart images for reports and presentations.

AfghanistanAccess to anti-retroviral drugs, male (%)Africa Eastern and SouthernAccess to anti-retroviral drugs, male (%)Africa Western and CentralAccess to anti-retroviral drugs, male (%)AlbaniaAccess to anti-retroviral drugs, male (%)AlgeriaAccess to anti-retroviral drugs, male (%)AngolaAccess to anti-retroviral drugs, male (%)Arab WorldAccess to anti-retroviral drugs, male (%)ArgentinaAccess to anti-retroviral drugs, male (%)ArmeniaAccess to anti-retroviral drugs, male (%)AustraliaAccess to anti-retroviral drugs, male (%)AzerbaijanAccess to anti-retroviral drugs, male (%)Bahamas, TheAccess to anti-retroviral drugs, male (%)BahrainAccess to anti-retroviral drugs, male (%)BangladeshAccess to anti-retroviral drugs, male (%)BarbadosAccess to anti-retroviral drugs, male (%)BelgiumAccess to anti-retroviral drugs, male (%)BelizeAccess to anti-retroviral drugs, male (%)BeninAccess to anti-retroviral drugs, male (%)BhutanAccess to anti-retroviral drugs, male (%)BoliviaAccess to anti-retroviral drugs, male (%)BotswanaAccess to anti-retroviral drugs, male (%)BulgariaAccess to anti-retroviral drugs, male (%)Burkina FasoAccess to anti-retroviral drugs, male (%)BurundiAccess to anti-retroviral drugs, male (%)Cabo VerdeAccess to anti-retroviral drugs, male (%)CambodiaAccess to anti-retroviral drugs, male (%)CameroonAccess to anti-retroviral drugs, male (%)CanadaAccess to anti-retroviral drugs, male (%)Central African RepublicAccess to anti-retroviral drugs, male (%)ChadAccess to anti-retroviral drugs, male (%)ChileAccess to anti-retroviral drugs, male (%)ColombiaAccess to anti-retroviral drugs, male (%)ComorosAccess to anti-retroviral drugs, male (%)Congo, Dem. Rep.Access to anti-retroviral drugs, male (%)Congo, Rep.Access to anti-retroviral drugs, male (%)Costa RicaAccess to anti-retroviral drugs, male (%)Cote d'IvoireAccess to anti-retroviral drugs, male (%)CroatiaAccess to anti-retroviral drugs, male (%)CubaAccess to anti-retroviral drugs, male (%)DenmarkAccess to anti-retroviral drugs, male (%)DjiboutiAccess to anti-retroviral drugs, male (%)Dominican RepublicAccess to anti-retroviral drugs, male (%)EcuadorAccess to anti-retroviral drugs, male (%)EgyptAccess to anti-retroviral drugs, male (%)El SalvadorAccess to anti-retroviral drugs, male (%)EritreaAccess to anti-retroviral drugs, male (%)EstoniaAccess to anti-retroviral drugs, male (%)EswatiniAccess to anti-retroviral drugs, male (%)EthiopiaAccess to anti-retroviral drugs, male (%)Euro areaAccess to anti-retroviral drugs, male (%)FijiAccess to anti-retroviral drugs, male (%)Fragile and conflict affected situationsAccess to anti-retroviral drugs, male (%)FranceAccess to anti-retroviral drugs, male (%)GabonAccess to anti-retroviral drugs, male (%)Gambia, TheAccess to anti-retroviral drugs, male (%)GeorgiaAccess to anti-retroviral drugs, male (%)GhanaAccess to anti-retroviral drugs, male (%)GreeceAccess to anti-retroviral drugs, male (%)GuatemalaAccess to anti-retroviral drugs, male (%)GuineaAccess to anti-retroviral drugs, male (%)Guinea-BissauAccess to anti-retroviral drugs, male (%)GuyanaAccess to anti-retroviral drugs, male (%)HaitiAccess to anti-retroviral drugs, male (%)Heavily indebted poor countries (HIPC)Access to anti-retroviral drugs, male (%)HondurasAccess to anti-retroviral drugs, male (%)IcelandAccess to anti-retroviral drugs, male (%)IDA blendAccess to anti-retroviral drugs, male (%)IDA onlyAccess to anti-retroviral drugs, male (%)IDA totalAccess to anti-retroviral drugs, male (%)IndonesiaAccess to anti-retroviral drugs, male (%)IraqAccess to anti-retroviral drugs, male (%)IrelandAccess to anti-retroviral drugs, male (%)ItalyAccess to anti-retroviral drugs, male (%)JamaicaAccess to anti-retroviral drugs, male (%)JordanAccess to anti-retroviral drugs, male (%)KazakhstanAccess to anti-retroviral drugs, male (%)KenyaAccess to anti-retroviral drugs, male (%)KuwaitAccess to anti-retroviral drugs, male (%)Kyrgyz RepublicAccess to anti-retroviral drugs, male (%)Lao PDRAccess to anti-retroviral drugs, male (%)LatviaAccess to anti-retroviral drugs, male (%)Least developed countries: UN classificationAccess to anti-retroviral drugs, male (%)LebanonAccess to anti-retroviral drugs, male (%)LesothoAccess to anti-retroviral drugs, male (%)LiberiaAccess to anti-retroviral drugs, male (%)LibyaAccess to anti-retroviral drugs, male (%)LithuaniaAccess to anti-retroviral drugs, male (%)LuxembourgAccess to anti-retroviral drugs, male (%)MadagascarAccess to anti-retroviral drugs, male (%)MalawiAccess to anti-retroviral drugs, male (%)MalaysiaAccess to anti-retroviral drugs, male (%)MaldivesAccess to anti-retroviral drugs, male (%)MaliAccess to anti-retroviral drugs, male (%)MaltaAccess to anti-retroviral drugs, male (%)MauritaniaAccess to anti-retroviral drugs, male (%)MexicoAccess to anti-retroviral drugs, male (%)Middle East, North Africa, Afghanistan & PakistanAccess to anti-retroviral drugs, male (%)Middle East, North Africa, Afghanistan & Pakistan (excluding high income)Access to anti-retroviral drugs, male (%)Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)Access to anti-retroviral drugs, male (%)MoldovaAccess to anti-retroviral drugs, male (%)MongoliaAccess to anti-retroviral drugs, male (%)MontenegroAccess to anti-retroviral drugs, male (%)MoroccoAccess to anti-retroviral drugs, male (%)MozambiqueAccess to anti-retroviral drugs, male (%)MyanmarAccess to anti-retroviral drugs, male (%)NamibiaAccess to anti-retroviral drugs, male (%)NepalAccess to anti-retroviral drugs, male (%)NetherlandsAccess to anti-retroviral drugs, male (%)New ZealandAccess to anti-retroviral drugs, male (%)NigerAccess to anti-retroviral drugs, male (%)NigeriaAccess to anti-retroviral drugs, male (%)North MacedoniaAccess to anti-retroviral drugs, male (%)OmanAccess to anti-retroviral drugs, male (%)Other small statesAccess to anti-retroviral drugs, male (%)PakistanAccess to anti-retroviral drugs, male (%)PanamaAccess to anti-retroviral drugs, male (%)Papua New GuineaAccess to anti-retroviral drugs, male (%)ParaguayAccess to anti-retroviral drugs, male (%)PeruAccess to anti-retroviral drugs, male (%)PhilippinesAccess to anti-retroviral drugs, male (%)PortugalAccess to anti-retroviral drugs, male (%)Pre-demographic dividendAccess to anti-retroviral drugs, male (%)QatarAccess to anti-retroviral drugs, male (%)RomaniaAccess to anti-retroviral drugs, male (%)RwandaAccess to anti-retroviral drugs, male (%)Saudi ArabiaAccess to anti-retroviral drugs, male (%)SenegalAccess to anti-retroviral drugs, male (%)SerbiaAccess to anti-retroviral drugs, male (%)Sierra LeoneAccess to anti-retroviral drugs, male (%)SingaporeAccess to anti-retroviral drugs, male (%)SlovakiaAccess to anti-retroviral drugs, male (%)SloveniaAccess to anti-retroviral drugs, male (%)Somalia, Fed. Rep.Access to anti-retroviral drugs, male (%)South AfricaAccess to anti-retroviral drugs, male (%)South SudanAccess to anti-retroviral drugs, male (%)SpainAccess to anti-retroviral drugs, male (%)Sri LankaAccess to anti-retroviral drugs, male (%)Sub-Saharan Africa Access to anti-retroviral drugs, male (%)Sub-Saharan Africa (excluding high income)Access to anti-retroviral drugs, male (%)Sub-Saharan Africa (IDA & IBRD countries)Access to anti-retroviral drugs, male (%)SudanAccess to anti-retroviral drugs, male (%)SurinameAccess to anti-retroviral drugs, male (%)SwedenAccess to anti-retroviral drugs, male (%)SwitzerlandAccess to anti-retroviral drugs, male (%)Syrian Arab RepublicAccess to anti-retroviral drugs, male (%)TajikistanAccess to anti-retroviral drugs, male (%)TanzaniaAccess to anti-retroviral drugs, male (%)ThailandAccess to anti-retroviral drugs, male (%)Timor-LesteAccess to anti-retroviral drugs, male (%)TogoAccess to anti-retroviral drugs, male (%)TunisiaAccess to anti-retroviral drugs, male (%)UgandaAccess to anti-retroviral drugs, male (%)United Arab EmiratesAccess to anti-retroviral drugs, male (%)United KingdomAccess to anti-retroviral drugs, male (%)Venezuela, RBAccess to anti-retroviral drugs, male (%)VietnamAccess to anti-retroviral drugs, male (%)WorldAccess to anti-retroviral drugs, male (%)Yemen, Rep.Access to anti-retroviral drugs, male (%)ZambiaAccess to anti-retroviral drugs, male (%)ZimbabweAccess to anti-retroviral drugs, male (%)